ICON Bioscience
Closed portfolio snapshot
According to ClinicalTrials.gov-derived indexes, ICON Bioscience sits in the upper quartile of US sponsors by registered trial count (#2,411 of 15,742 sponsors by registered trial count).
ICON Bioscience: 5 sponsored US clinical trials, none currently recruiting.
ICON Bioscience sponsors 5 registered US clinical trials on ClinicalTrials.gov, none currently recruiting, and 3 completed. 2 of these trials are in Phase 3-4 (later-stage) and 3 in Phase 1-2 (earlier-stage). The most-studied condition in this pipeline is Inflammation Associated With Cataract Surgery, with 1 trials.
Upper-quartile sponsor footprint
ICON Bioscience sits in the upper quartile of the sponsor corpus (#2,411 of 15,742 sponsors by registered trial count) - denser than most sponsors, still short of the top-decile hubs.
Indexed trials (enrollment closed)
5 total, page 1 of 1
Study to Evaluate the Safety for the Treatment of Inflammation Associated With Cataract Surgery
NCT02547623
The Efficacy and Safety of IBI-10090 for the Treatment of Inflammation Associated With Cataract Surgery
NCT02006888
Efficacy and Safety of IBI-10090 in Ocular Surgery Patients
NCT01606735
Efficacy and Safety Study of IBI-10090 in Cataract Surgery Patients
NCT01214174
Efficacy and Safety Study of IBI-10090 in Patients Undergoing Cataract Surgery
NCT01048593
Phase Distribution
| Phase | Trial count |
|---|---|
| Phase 2 | 3 |
| Phase 3 | 2 |
Therapeutic Areas
How the ICON Bioscience archive is shaped
5 indexed studies, none listed as recruiting (0% open); 3 completed (60%).
Phase mix: 2 late (III/IV) vs 3 early (I/II) (balanced across stages).
Top condition: Inflammation Associated With Cataract Surgery (1 trial), 0 others listed.
How to read a closed sponsor archive
When recruiting_count is zero, the indexed set is completed or otherwise not open. Phase tilt still describes where archived studies sat on the investigational pathway. Re-check ClinicalTrials.gov before acting.
ICON Bioscience: archived-pipeline peers nationwide
Peers matched on 5 indexed studies with no current recruiting: volume and archive shape, not condition overlap.
ICON Bioscience sits at or above the median trial volume and at or above the median recruiting share among these 9 nationwide peers -- the two do not always move together.
Sponsors near 5 archived trials
- 4YouandMe · 5 trials · 0% recruiting
- Abbott Rapid Dx · 5 trials · 0% recruiting
- Access Business Group · 5 trials · 0% recruiting
- Acera Surgical · 5 trials · 20% recruiting
Sponsors with similar archive density (± trial count)
- 10xBio · 0% recruiting · 3 trials
- 22nd Century Group · 0% recruiting · 3 trials
- 23andMe · 0% recruiting · 6 trials
- 3-C Institute for Social Development · 0% recruiting · 14 trials
Related
What to do with this ICON Bioscience page
5 registered trials is a research-attention snapshot, not an endorsement of ICON Bioscience or any single study.
- None of ICON Bioscience's trials are currently recruiting in this registry; that can change as new trials post, or check the broader research index. Browse research indexes
- Inflammation Associated With Cataract Surgery is the condition ICON Bioscience studies most, compare against other sponsors active in the same condition before evaluating a specific study. See Inflammation Associated With Cataract Surgery trials
- Bring the specific trial ID (NCT number) to your own doctor before enrolling, this page is a directory, not medical guidance. Read the trial-finding guide
Trial and recruiting counts reflect ClinicalTrials.gov registry status as of the data vintage above; individual trial eligibility and enrollment status can change.
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. ICON Bioscience pipeline card: 5 registered trials from official public datasets. See our editorial standards & corrections policy, the methodology behind these numbers, the data changelog, or report a data error.